Dobutamine stress echocardiography: False positive scans in proteinuric patients with type 1 diabetes mellitus at high risk of ischaemic heart disease

Diabetic Medicine

Volumn 15, Issue 5, 1998, Pages 427-430

  Griffin, M E ^a,b   Nikookam, K ^a   Teh, M M ^a   McCann, H ^a   O'Meara, N M ^a   Firth, R G ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dobutamine stress; Echocardiography; False positive; Nephropathy, ischaemic heart disease; Type 1 diabetes mellitus

Indexed keywords

DOBUTAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MALE; STRESS ECHOCARDIOGRAPHY;

ADULT; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DOBUTAMINE; ECHOCARDIOGRAPHY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PROTEINURIA; RISK FACTORS;

EID: 0031958178     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199805)15:5<427::AID-DIA593>3.0.CO;2-O     Document Type: Article

References (23)

1. Barrett-Connor E, Orchard T. Diabetes and heart disease. In: National Diabetes Data Group, eds. Diabetes in America. NIH Publication no. 85-1468. Bethesda, MD: National Institutes of Health, 1985: 1-41.
2. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metabolism Rev 1987; 3: 463-524.
3. Borch-Johnsen K, Kragh Anderson P, Deckert T. The effect of proteinuria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28: 590-596.
4. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 1987; 294: 1651-1654.
5. Jensen T, Borch-johnsen K, Kofoed-Enevolsen A, Deckert T. Coronary heart disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987; 30: 44-48.
6. Krolewski AS, Kosinski EJ, Warram JH, Leland S, Busick EJ, Asmal AC, et al. Magnitude and determinants of coronary artery disease in juvenile onset, insulin dependent diabetes mellitus. Am J Cardiol 1987; 59: 750-755.
7. Scheidt-Nave C, Barrett-Connor E, Wingard DL. Resting electrocardiographic abnormalities suggestive of asymptomatic ischaemic heart disease associated with non-insulin-dependent diabetes mellitus in a defined population. Circulation 1990; 81: 899-906.
8. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. Br Med J 1990; 301: 92-95.
9. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991; 90: 563-570.
10. Bell DS, Yumuk VD. Low incidence of false positive exercise thallium 201 scintigraphy in a diabetic population. Diabetes Care 1996; 19: 185.
11. Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa PH. Detection of coronary artery disease in diabetic patients. Diabetologia 1995; 38: 726-731.
12. Previtali M, Lanzarini L, Fetiveau R, Poli A, Ferrario M, Falcone C, Mussini A. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for the diagnosis of coronary artery disease. Am J Cardiol 1993; 72: 865-870.
13. Reis G, Marcovitz PA, Leichtmann AB, Merrion RM, Fay WP, Werns SW, Armstrong WF. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal failure. Am J Cardiol 1995; 75: 707-710.
14. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications and correlations. Mayo Clin Proc 1995; 70: 16-27.
15. Afridi I, Quinones MA, Zoghbi WA, Cheirif JB. Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. Am Heart J 1994; 127: 1510-1515.
16. Bach DS, Hepner A, Marcvitz PA, Armstrong WF. Dobutamine stress echocardiography prevalence of nonischaemic response in a low risk population. Am Heart J 1993; 125: 1257-1261.
17. Bates JR, Sawada SG, Segar DS, Spaedy AJ, Petrovic O, Fineberg NS, Feigenbaum H, Ryan T. Evaluation using dobutamine stress echocardiography in patients with insulin dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996; 77: 175-179.
18. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605-1614.
19. Bell DSH. Diabetic cardiomyopathy a unique entity or a complication of coronary artery disease? Diabetes Care 1995; 18: 708-714.
20. Factor SM, Okum EM, Minase T. Capillary microanneurysm in the human diabetic heart. N Engl J Med 1980; 302: 384-388.
21. Eichelberger JP, Schwarz KQ, Black ER, Green RM, Ouriel K. Predictive value of echocardiography just before noncardiac vascular surgery. Am J Cardiol 1993; 72: 602-607.
22. Wu C-C, Ho Y-L, Kao S-L, Chen W-J, Lee C-M, Chen M-F, et al. Dobutamine stress echocardiography for detecting coronary artery disease. Cardiology 1996; 87: 244-249.
23. Madu EC, Price A, Harris T, Badran H, Rouse C, Ramanathan KB. Sustained nonischaemic ventricular tachycardia during dobutamine stress echocardiography. Cardiology 1996; 87: 82-85.